Emerging Therapies in Multiple Sclerosis: Perspectives and Future
DOI:
https://doi.org/10.36557/2674-8169.2023v5n5p4828-4841Keywords:
Esclerose Múltipla; Terapias Emergentes; Personalização do Tratamento.Abstract
This research investigates the progression of emerging therapies in the treatment of multiple sclerosis (MS), emphasizing the significance of these approaches in managing this intricate neurological condition. Emerging therapies play a crucial role in the pursuit of more effective and targeted alternatives, surpassing conventional approaches to immunomodulation and symptomatic control. The comprehensive analysis of these options aims to provide healthcare professionals with a deep understanding of the latest and innovative strategies, taking into account factors such as disease progression and patients' quality of life.
The determination of emerging therapies in MS is multifaceted, influenced by variables such as the patient's genetic profile, disease stage, and response to previous treatments. In this context, the comparative evaluation of different approaches, including advanced immunotherapies, cellular therapies, and genetic interventions, becomes imperative to ensure treatment effectiveness and minimize potential adverse effects.
Furthermore, treating MS with emerging therapies represents a complex challenge that requires an integrated approach. This research explores various therapeutic modalities, from pharmacological interventions to non-pharmacological methods, with the aim of providing valuable insights to optimize MS management and enhance the quality of life for post-treatment patients. Understanding the complexities and nuances of these therapies is crucial to ensure comprehensive and personalized care for MS patients, highlighting the importance of a holistic approach in managing this neurodegenerative condition.
Ultimately, this article aims to consolidate up-to-date information on emerging therapies in multiple sclerosis, providing a critical analysis of the available scientific literature. The goal is to contribute to the continuous development of clinical practices in this area, promoting the effectiveness of procedures and improving the quality of life for patients facing this challenging neurological condition.
Downloads
References
Ahn, J. J. et al. B cell depletion modulates glial responses and enhances blood vessel integrity in a model of multiple sclerosis. Neurobiology of Disease, v. 187, p. 106290, 2023.
Boldrini, V. O. et al. Cytotoxic B Cells in Relapsing-Remitting Multiple Sclerosis Patients. Front. Immunol., v. 13, p. 750660, 2022.
Carlson, A. K. et al. Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis: The Age of PIRA. Neurol Clin, v. 42, p. 39–54, 2023.
Kanatas, P. et al. B-Cell-Directed Therapies: A New Era in Multiple Sclerosis Treatment. The Canadian Journal of Neurological Sciences, v. 50, p. 355–364, 2023.
Kim, E. et al. Co-occurrence of glioma and multiple sclerosis: Prevailing theories and emerging therapies. Multiple Sclerosis and Related Disorders, v. 79, p. 105027, 2023.
Liu, C. et al. Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis. Journal of Neuroinflammation, v. 19, p. 298, 2022.
Peterson, S. et al. Updates on efficacy and safety outcomes of new and emerging disease-modifying therapies and stem cell therapy for Multiple Sclerosis: A review. Multiple Sclerosis and Related Disorders, v. 68, p. 104125, 2022.
Saberi, D. et al. Bruton’s tyrosine kinase as a promising therapeutic target for multiple sclerosis. EXPERT OPINION ON THERAPEUTIC TARGETS, v. 27, n. 4-5, p. 347-359, 2023.
Simpson, A., Mowry, E. M., Newsome, S. D. Early Aggressive Treatment Approaches for Multiple Sclerosis. Curr Treat Options Neurol, v. 23, p. 19, 2021.
Song, Y. et al. Real-world treatment patterns and effectiveness of cladribine tablets in patients with relapsing forms of multiple sclerosis in the United States. Multiple Sclerosis and Related Disorders, v. 79, p. 105052, 2023.
Yang, J. H. et al. Therapeutic Advances in Multiple Sclerosis. Front. Neurol., v. 13, p. 824926, 2022.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Maria Eduarda Andrade Trajano dos Santos , Gabriel Silva Fideli, Walter Rodrigues Marques Júnior, Stéfany de Amorim Mendonça , Conrado Vilela Vargas
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are copyright holders under a CCBY 4.0 license.
